Sirio launches women’s health platform at Vitafoods Europe

Published: 27-Mar-2024

The formulation range targets issues as diverse as PMS, fertility, prenatal & postnatal care and menopause wellbeing

New ready-to-launch formulation range features premium branded ingredients, and targets issues as diverse as PMS, fertility, prenatal & postnatal care and menopause wellbeing.

Sirio Pharma – the global nutraceutical contract development and manufacturing organisation (CDMO) – is launching a novel women’s health platform at Vitafoods Europe. 

The new 25 formulation-strong portfolio is personalised to women’s health needs and life stages, with products covering puberty to post menopause.

Sirio utilised its global R&D capabilities to simultaneously introduce the comprehensive and premium range, with products supported by branded ingredients, consumer trends, clinical data and stability studies.

“Women’s health focused on individual life stage is the big trend of 2024. Our team researched this early to undertake all the complex formulation options, science and segmenting of product types. Essentially, we have done the hard work so that our nutraceutical brand partners can launch more quickly to market with first-in-class products,” commented Sara Lesina, General Manager Sirio Europe & Americas.

Three of these products will be on display at Vitafoods Europe in Geneva (14-16 May, 2024).These include a first-to-the market “MenoBalance” Gummy, which utilises Novasoy, a type of soy isoflavone from ADM. 

This is the first time Novasoy has been successfully delivered in a gummy. 

In terms of science, existing evidence shows that soy isoflavones may reduce the number and frequency of hot flashes and may help maintain healthy bones following the transition into menopause.

ADM is a global company specialising in human nutrition with over 50 pre-clinical and human clinical studies ongoing, helping to bring tailored offerings to market.

Additionally, post-natal and pre-natal formulations with branded ingredients from KD Nutra and Gnosis by Lesaffre respectively will also be showcased. 

The "Me&Mum" post-natal softgel is an all-in-one concept – featuring a complex formulation including DHA, vitamins and minerals, as well as herbal extracts that help with hormonal hair loss.

The InnoFolate prenatal softgel, featuring Sirio’s vegan Plantegrity technology, is a prenatal formulation powered by Quatrefolic from Gnosis by Lesaffre – shown to help maintain folate levels during pregnancy – and combines an essential nutrient mix including DHA.

Sirio’s new full product line includes both gummies and softgels, spanning general women’s health products like menstrual care, UTI protection, gut health (pre and post biotics), sleep health and weight management. 

Additionally, the range also caters to specific life stages and individual health concerns with specially formulated products for fertility, morning sickness [during pregnancy], prenatal care, postnatal symptoms and health – including improved energy, hair loss, fatigue and brain fog – and a range of menopausal softgels and gummies.


You may also like